BY ULRICH QUISTGAARD
-
First company voluntarily shares vaccine data in WHO collaboration: Ensuring pandemic preparedness against avian flu
Washington has additionally awarded USD 176 million to Moderna to develop an avian flu vaccine towards H5N1.
-
Sanofi targets Germany with EUR 1.3 billion-insulin plant
Along with Sanofi, Japanese pharmaceutical firm Daiichi Sankyo and US firm Eli Lilly have introduced main investments in Germany.
-
BMS reprioritizes research investments and stops phase III study
Bristol Myers Squibb had deliberate a 466-patient part III examine to analyze progression-free survival in myeloma sufferers with the candidate, which is now dropped as a substitut…
-
Boehringer Ingelheim acquires US cancer company in USD 1.3 billion-deal
Boehringer Ingelheim sees new alternatives in most cancers therapy by way of American Nerio Therapeutics’ checkpoint inhibitors, and the acquisition consists of the acquisition of …
-
Novo Nordisk mulls financial consequences for suppliers with illegal employees
After heavy media criticism of situations at Novo Nordisk’s building website in Kalundborg, the pharmaceutical firm is contemplating imposing monetary sanctions on suppliers with u…
-
Leo chairman looking for Jan van de Winkel’s replacement
Jan van de Winkel actions down from the board of Leo Pharma to concentrate all his time on his work as chief executive officer of Genmab.
-
Novo Nordisk mulls financial consequences for suppliers with illegal employees
After heavy media criticism of conditions at Novo Nordisk’s construction site in Kalundborg, the pharmaceutical company is considering imposing financial sanctions on suppliers wit…
